Studies have shown that
colestyramine reduces the
serum levels of the active
metabolite of
leflunomide by up to 65%.
Patients taking
leflunomide should not be given
colestyramine unless it is needed to washout' the
leflunomide, such as in overdosage or when switching to another DMARD.